Navigation Links
Synvista Therapeutics Announces Data Further Demonstrating the Value of Haptoglobin Genotyping in Diabetic Patients During AHA Meeting
Date:11/11/2008

ne year of angioplasty, and of heart failure and death following a heart attack. Prospective, randomized, clinical trials have demonstrated that the rate of heart attack in Hp2-2 diabetes can be decreased by the administration of natural vitamin E (400IU).

About Synvista Therapeutics

Synvista Therapeutics is a biopharmaceutical company developing clinical laboratory tests and drugs to diagnose, treat and prevent cardiovascular disease in people with diabetes. The Company has developed a protein-based clinical test to identify patients with Hp2-2 diabetes. This test, or a similar genetic form of the test, may be useful in identifying diabetic patients at high risk for cardiovascular complications. These patients may benefit from a particular formulation of vitamin E. The Company is also developing a kit to measure CML (carboxy-methyllysine), another potential cardiovascular risk marker.

Synvista Therapeutics is developing oral antioxidant drugs to treat the HDL dysfunction seen in Hp2-2 diabetes, a disease affecting almost 7 million patients in the United States. The Company is also developing alagebrium, a proposed breaker of advanced glycation endproducts (AGEs) for the treatment of systolic and diastolic heart failure.

For more information, please visit the Company's Web site at http://www.synvista.com.

Any statements contained in this press release that relate to future plans, events or performance are forward-looking statements that involve risks and uncertainties including, but not limited to, the risks associated with the events described in this press release, future clinical development of Synvista Therapeutics' diagnostic tests and product candidates, and other risks identified in Synvista Therapeutics' filings with the Securities and Exchange Commission. Further information on risks faced by Synvista are detailed under the caption "Risk Factors" in Synvista Therapeutics'
'/>"/>

SOURCE Synvista Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Synvista Therapeutics to Present at the Rodman & Renshaw 10th Annual Healthcare Conference
2. Synvista Therapeutics Announces Availability of Haptoglobin Genotyping Technology at The Annual Scientific Sessions of the American Heart Association
3. Synvista Therapeutics Posts Letter to Stockholders on Web Site
4. Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
5. Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure
6. Synvista Therapeutics to Present at Acumen BioFin Rodman & Renshaw 5th Annual Global Healthcare Conference
7. Synvista Therapeutics Increases Commercial Focus by Appointing David C. Tantillo Senior Director of Marketing and Sales
8. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
9. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
10. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
11. Synvista Therapeutics to be Featured on Wallst.net

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... ,Primaryefficacyendpointhasbeenmetforpatientswith..., QUEBECCITY,Nov.24/PRNewswire-FirstCall/-AEternaZ...globalbiopharmaceuticalcompanyfocusedonendocrineth...afromaPhase2studywithitstargetedcytotoxicpeptideco...ancedorrecurrentendometrialcancer.Inapersonalizedh...
(Date:11/24/2009)..., REDWOODCITY,Calif.,Nov.24/PRNewswire-FirstCall/-...atRandyScott,GenomicHealth,sExecutiveChairman,will...enceinNewYorkCityonTuesday,December1,2009at10:00a....webcastofthepresentation,visittheInvestorRelations...genomichealth.com .Pleaseconnecttothewebsiteatleas...
(Date:11/24/2009)..., SEATTLE,Nov.24/PRNewswire-FirstCall/--CellTherap...resentatthe21stAnnualPiperJaffrayHealthCareConfere...ewYorkPalaceHotel. ,, CTIwillpresentonTuesday,D...AliveaudiowebcastofCTI,spresentationwillbeavailabl...ableforreplayafterwards. , ,PiperJaffrayHealthCar...
(Date:11/23/2009)...hene consists of a two-dimensional carbon layer in...l lattice, resembling a honeycomb. Carbon nanotube...s of graphene sheets form graphite. Graphene boast...ly tear-resistant, an excellent thermal conductor,...tleness and ductility. In addition, graphene is im...
Breaking Biology Technology:AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2Polymer with honeycomb structure 2
... to progress research from academic settings to ...apeutics -, BOSTON, Oct. 2 The promise of resear...ader than most might think,including not only the ...,also opportunities to understand development and ... diabetes, according to Arnold W. Donald,President...
...al Technology Conference Brings Together,Policy an... of leading health,care economists and physician-i...ed medical technology for improving patient care a...session, entitled "Value of Medical,Technology: In...2007, the,premier medical technology conference an...
..., Berkeley, UPenn Partner with Biocareercent...TA CRUZ, Calif., Oct. 2 According to the National...tists with PhDs and,post-doctorates are in the Uni...wing population receiving tenured positions at uni...quality jobs in the private and public,sectors. Bi...
Other Biology Technology:Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments 2Stem Cell Science Holds Opportunities as Important Tool for Diabetes Research Beyond Cell-Based Treatments 3Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference 2Top Health Care Economists and Physician-Innovators Discuss Value of Medical Technology at AdvaMed 2007 Conference 3Bio Career Center Launches First Online Jobs Board for Life Science PhDs, MDs 2
(Date:11/24/2009)... Medical Toxicology (ACMT) have signed an agreemen...l of Medical Toxicology (JMT), the official journ...reviously published by the University of Pennsylva... , an international, peer-reviewed journal, is ded...dical toxicology. The quarterly journal focuses o...
(Date:11/24/2009)...sh . , The presence of increased body fat, a...ces in the blood, hinders the loss and maintenance... the University of Navarra conducted by Estbaliz G...acy. , The project, entitled "A nutrigenetic and...body weight and inflammation," examines how the in...
(Date:11/23/2009)...vation Society says that western lowland gorillas ...rt of the "mother lode" of more than 125,000 goril...threatened by growing humans activity in the regio...p forests adjacent to the southwest border of Lac ...d that high densities of the great apes still exis...
Breaking Biology News(10 mins):Springer and the American College of Medical Toxicology to work together 2It can be predicted the reaction obese patients will have to a diet 2A year after discovery, Congo's 'mother lode' of gorillas remains vulnerable 2Foreclosures Plunge People Into Depression 54848 1Foreclosures Plunge People Into Depression 54848 2FDA Accepts Drug Application for Miconazole Lauriad 28R 29 to Treat Oropharyngeal Candidiasis 54844 1FDA Accepts Drug Application for Miconazole Lauriad 28R 29 to Treat Oropharyngeal Candidiasis 54844 2FDA Accepts Drug Application for Miconazole Lauriad 28R 29 to Treat Oropharyngeal Candidiasis 54844 3The HRSA Genetics Collaboratives are Bringing Genetic and Newborn Screening Services to Local Communities Around the United States 54841 1The HRSA Genetics Collaboratives are Bringing Genetic and Newborn Screening Services to Local Communities Around the United States 54841 2The HRSA Genetics Collaboratives are Bringing Genetic and Newborn Screening Services to Local Communities Around the United States 54841 3The HRSA Genetics Collaboratives are Bringing Genetic and Newborn Screening Services to Local Communities Around the United States 54841 4
...esearchers at the University of North Carolina at ...er have synthetically reconstructed the bat varian...RS epidemic of 2003. , The scientists say design...ward in their ability to find effective vaccines a...ght affect humans in the future. , A report of th...
... Children,s Hospital of Pittsburgh of UPMC have be... in an animal model using a novel population of st...n skeletal muscle tissue. , The research team le...rified from human muscle-derived blood vessels int... to that which would occur in people who had suffe...
...fruit fly from the Seychelles Islands often lays l...e discovered. Clues to how animals switch from lay...udied species, ecology and genes. , The fly is on...y had their genomes sequenced, information that sh...g genetic changes that cause females of this speci...
Other Biology News:Researchers recreate SARS virus, open door for potential defenses against future strains 2Children's Hospital scientists achieve repair of injured heart muscle in lab tests of stem cells 2Flies may reveal evolutionary step to live birth 2
Sheep Anti-Mouse GDF-8 Polyclonal Antibodies, from R&D Systems
Goat Anti-Human Serpin B5 / Maspin Polyclonal Antibody, Unconjugated from R&D Systems
Rabbit Anti-SOX10 Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Rabbit Anti-Human GMNN Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
Biology Products: